Dr. Karen Kuhlthau, PhD
Claim this profileStudies Autism Spectrum Disorder
Studies Autism
1 reported clinical trial
3 drugs studied
Clinical Trials Karen Kuhlthau, PhD is currently running
More about Karen Kuhlthau, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Karen Kuhlthau, PhD has experience with
- Alpha 2 Agonist
- Amphetamine
- Methylphenidate
Breakdown of trials Karen Kuhlthau, PhD has run
Autism Spectrum Disorder
Pervasive Developmental Disorder
Attention Deficit Hyperactivity Disorder (ADHD)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Karen Kuhlthau, PhD specialize in?
Karen Kuhlthau, PhD focuses on Autism Spectrum Disorder and Autism. In particular, much of their work with Autism Spectrum Disorder has involved treating patients, or patients who are undergoing treatment.
Is Karen Kuhlthau, PhD currently recruiting for clinical trials?
Yes, Karen Kuhlthau, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Karen Kuhlthau, PhD has studied deeply?
Yes, Karen Kuhlthau, PhD has studied treatments such as Alpha 2 agonist, Amphetamine, Methylphenidate.
What is the best way to schedule an appointment with Karen Kuhlthau, PhD?
Apply for one of the trials that Karen Kuhlthau, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.